
{{Act of Congress
| congress       = 113
| session        = 1
| title          = To provide for the establishment of the Tick-Borne Diseases Advisory Committee.
| year           = 2013
| month          = 02
| day            = 12
| bill           = 610
| billtype       = hr
| purpose        = To provide for the establishment of the Tick-Borne Diseases Advisory Committee.
}}

{{Center|113th CONGRESS}}


{{Center|1st Session}}


{{Center|H. R. 610}}


{{Center|IN THE HOUSE OF REPRESENTATIVES}}


{{Center|February 12, 2013}}


{{Center|
[[w:Chris Smith (New Jersey politician)|Mr. Smith of New
			 Jersey]] (for himself, 
[[w:Frank Wolf|Mr.
			 Wolf]], 
[[w:Chris Gibson (New York politician)|Mr. Gibson]], and
			 
[[w:Collin Peterson|Mr. Peterson]]) introduced the following
			 bill; which was referred to the [[w:United States House Committee on Energy and Commerce|Committee
			 on Energy and Commerce]]}}


{{Center|A BILL}}

To provide for the establishment of the Tick-Borne
		  Diseases Advisory Committee.

={{anchor|H1A75933E8496458BA5C0A447FAA9B901}}Section 1. Establishment of a tick-borne
			 diseases advisory committee=



=={{anchor|H50CEDB4A6D924364BDA908B3F9A91038}}(a) Establishment– ==

Not
			 later than 180 days after the date of the enactment of this Act, the [[w:Department of Health and Human Services|Secretary
			 of Health and Human Services]] (referred to in this Act as the
			 “Secretary”) shall establish within the [[w:|Office of the Secretary]] an
			 advisory committee to be known as the [[w:|Tick-Borne Diseases Advisory Committee]]
			 (referred to in this section as the “Committee”).

=={{anchor|HD9F8E283AD4B47A487E0DF43E1C67CDF}}(b) Duties– ==

The
			 [[w:|Committee]] shall advise the [[w:Department of Health and Human Services|Secretary]] and the [[w:Surgeon General of the United States|Assistant Secretary for Health]]
			 regarding the manner in which such officials can—
:(1) ensure interagency
			 coordination and communication and minimize overlap regarding efforts to
			 address tick-borne diseases;
:(2) identify
			 opportunities to coordinate efforts with other Federal agencies and private
			 organizations addressing such diseases;
:(3) ensure interagency
			 coordination and communication with constituency groups;
:(4) ensure that a
			 broad spectrum of scientific viewpoints is represented in public health policy
			 decisions and that information disseminated to the public and physicians is
			 balanced; and
:(5) advise relevant
			 Federal agencies on priorities related to the Lyme and tick-borne
			 diseases.

=={{anchor|HC0E1B3962F724135A2B0EAAF5383DA4F}}(c) Membership– ==



==={{anchor|HF19E39C2EEF24BBA8C34E1BFC0E97ABF}}(1) Appointed
			 members– ===



===={{anchor|H352A8E924FE64148A87819E12DB17181}}(A) In
			 general– ====

The [[w:Department of Health and Human Services|Secretary]] shall appoint the voting members of the
			 [[w:|Committee]] from among individuals who are not officers or employees of the
			 Federal Government.

===={{anchor|H31639863972F4B82B0B9D1A7FB7D4719}}(B) Groups– ====

The
			 voting members of the [[w:|Committee]] shall include the following:
:(i) At
			 least 4 members from the scientific community representing the broad spectrum
			 of viewpoints held within the scientific community related to Lyme and other
			 tick-borne diseases.
:(ii) At
			 least 2 representatives of tick-borne disease voluntary organizations.
:(iii) At
			 least 2 health care providers, including at least 1 full-time practicing
			 physician, with relevant experience providing care for individuals with a broad
			 range of acute and chronic tick-borne diseases.
:(iv) At
			 least 2 patient representatives who are individuals who have been diagnosed
			 with a tick-borne disease or who have had an immediate family member diagnosed
			 with such a disease.
:(v) At
			 least 2 representatives of State and local health departments and national
			 organizations that represent State and local health professionals.

===={{anchor|HC4A2AFCA34B2437A9FF2B4ACEE6FB943}}(C) Diversity– ====

In
			 appointing members under this paragraph, the [[w:Department of Health and Human Services|Secretary]] shall ensure that such
			 members, as a group, represent a diversity of scientific perspectives relevant
			 to the duties of the [[w:|Committee]].

==={{anchor|HDE26545F88E54B75901F416C9385D0E7}}(2) Ex officio
			 members– ===

The [[w:Department of Health and Human Services|Secretary]] shall designate, as nonvoting, ex officio
			 members of the [[w:|Committee]], representatives overseeing tick-borne disease
			 activities from each of the following Federal agencies:
:(A) The [[w:Centers for Disease Control and Prevention|Centers for
			 Disease Control and Prevention]].
:(B) The [[w:National Institutes of Health|National
			 Institutes of Health]].
:(C) The [[w:Agency for Healthcare Research and Quality|Agency for
			 Healthcare Research and Quality]].
:(D) The [[w:Food and Drug Administration|Food and Drug
			 Administration]].
:(E) The [[w:Surgeon General of the United States|Office of the
			 Assistant Secretary for Health]].
:(F) Such additional
			 Federal agencies as the [[w:Department of Health and Human Services|Secretary]] determines to be appropriate.

==={{anchor|HC80DF41A7F334C9CAC6E886380AD3F1E}}(3) Co-chairpersons– ===

The
			 [[w:Department of Health and Human Services|Secretary]] shall designate the [[w:Surgeon General of the United States|Assistant Secretary for Health]] as the
			 co-chairperson of the [[w:|Committee]]. The appointed members of the [[w:|Committee]] shall
			 also elect a public co-chairperson. The public co-chairperson shall serve a
			 2-year term.

==={{anchor|HA63CA437575F49E8B1724E8810B03ACC}}(4) Term of
			 appointment– ===

The term of service for each member of the [[w:|Committee]]
			 appointed under paragraph (1) shall be 4 years.

==={{anchor|H08B7D0899AFD46068FB8FDDBC7841FBD}}(5) Vacancy– ===

A
			 vacancy in the membership of the [[w:|Committee]] shall be filled in the same manner
			 as the original appointment. Any member appointed to fill a vacancy for an
			 unexpired term shall be appointed for the remainder of that term. Members may
			 serve after the expiration of their terms until their successors have taken
			 office.

=={{anchor|H87973EB0E2B740149416FB56AC7A677D}}(d) Meetings– ==

The
			 [[w:|Committee]] shall hold public meetings, except as otherwise determined by the
			 [[w:Department of Health and Human Services|Secretary]], after providing notice to the public of such meetings, and shall
			 meet at least twice a year with additional meetings subject to the call of the
			 co-chairpersons. Agenda items with respect to such meetings may be added at the
			 request of the members of the [[w:|Committee]], including the co-chairpersons.
			 Meetings shall be conducted, and records of the proceedings shall be
			 maintained, as required by applicable law and by regulations of the
			 Secretary.

=={{anchor|H1FCCA027975949289DCE644ED2AE8FA4}}(e) Report– ==

Not
			 later than 1 year after the date of the enactment of this Act, and annually
			 thereafter, the [[w:|Committee]], through the [[w:Centers for Disease Control and Prevention|Director of the Centers for Disease
			 Control]] and Prevention and the [[w:National Institutes of Health|Director of the National Institutes of Health]],
			 shall submit a report to the [[w:Department of Health and Human Services|Secretary]]. Each such report shall contain, at a
			 minimum—
:(1) a
			 description of the [[w:|Committee’s]] functions;
:(2) a
			 list of the [[w:|Committee’s]] members and their affiliations; and
:(3) a
			 summary of the [[w:|Committee’s]] activities and recommendations during the previous
			 year, including any significant issues regarding the functioning of the
			 [[w:|Committee]].

=={{anchor|HE44F6C8F3D9C4C50B9A93846DDAB0DEA}}(f) Authorization of
			 Appropriations– ==

Of the amounts made available to the [[w:Department of Health and Human Services|Department of
			 Health and Human Services]] for general departmental management for fiscal years
			 2013 through 2017, there is authorized to be appropriated $250,000 for each of
			 such fiscal yearsto carry outthis Act. Amounts made available to carry out
			 this Act shall be used for the expenses and per diem costs incurred by the
			 [[w:|Committee]] under this section in accordance with the Federal Advisory Committee
			 Act, except that no voting member of the [[w:|Committee]] shall be a permanent
			 salaried employee.